Introduction: Remarkable differences in quality of care (QoC) might be observed in different countries, affecting quality of life of inflammatory bowel disease (IBD) patients. A v a i l a b l e o n l i n e a t w w w . s c i e n c e d i r e c t . c o m
Introduction
Crohn's disease (CD) and ulcerative colitis (UC) are chronic recurrent inflammatory disorders that occur early in life and require long-term healthcare. The wide spectrum of disease severity and the possible occurrence of extraintestinal manifestations and perianal lesions might lead to intensive outpatient contact, hospitalisations and surgery. In patients with intensive courses of inflammatory bowel disease (IBD), the quality of life is impaired due to disease-related factors that influence the health related quality of life (HRQoL) [1] . As with other chronic conditions, the healthcare organisation might play an important role in the improvement of the QoL in IBD patients. The evaluation of the quality of healthcare (QoC) takes into account the quality of the services provided and the perception of the patients on the actual services delivered. In western modern healthcare, there is often a gap between the clinician's and the patient's perceptions of the quality of healthcare provided [2] [3] [4] . To assess the opinion of IBD patients on the healthcare provided in the past year, a specific questionnaire was developed [5, 6] , which combines the importance and performance evaluations on single items.
The SOLUTION observational study (Studio Osservazionale quaLità cUre malatTIe crOniche intestiNali) is an Italian multicentre study on the quality of care provided to IBD patients across Italy in IBD centres participating in the Italian Group for Inflammatory Bowel Disease (IG-IBD) with a special focus on the differences in patient and physician perspectives. The study includes a cross-sectional phase and a 12-month prospective phase to assess the variation in the QoC from the patient's perspective during a one-year follow-up related to the disease course.
This paper refers the results of the cross-sectional phase of the study (SOLUTION 1).
Patients and methods
The SOLUTION-1 is an observational study involving IG-IBD centres across Italy. From April 2010 until February 2011, consecutive outpatients and inpatients with diagnosis of Crohn's disease (CD) or ulcerative colitis (UC) were recruited. All the patients had diagnosis established by commonly accepted clinical, endoscopic and histological criteria. Patients with any of the following conditions were excluded from the study: -a diagnosis of less than 12 months at the time of enrolment or follow up at the centre for less than 12 months at the time of enrolment, -inclusion in other clinical trials at baseline or in the previous 12 months, -inability to understand or complete the study questionnaires, -age b 18 years.
Each patient provided written, informed consent to participate in the study. At the time of enrolment, all the patients were interviewed by a physician caring for IBD patients, and demographic and clinical details were collected. The demographic data included the age at enrolment, gender, educational level, marital status, employment status, and smoking habits. The clinical data included the year of symptom onset, the year of diagnosis, the extension or localisation of the disease, health status at enrolment, and outpatient or inpatient status. All the relevant data on the utilisation of healthcare resources related to IBD (hospitalisation, surgery, physician visits and diagnostic procedures) were recorded. IBD specific medical treatments undertaken in the previous year and on-going treatments were registered. The use of vitamins or other supplements (calcium, iron) were recorded. Clinical disease activity was assessed by the Harvey-Bradshaw Index [7] for patients with CD and by the Lichtiger Index (modified Truelove and Witts) [8] for patients with UC.
The QoC evaluation in IBD used the Quality of Care Through the Patient's Eyes (QUOTE-IBD) questionnaire [6] . The QUOTE-IBD questionnaire was designed based on the model created by the Netherlands Institute for Health Research Services to measure the quality of care perceived by the patient ("Quality Of Care Through the Patients' Eyes" -QUOTE). The QUOTE-IBD consists of 10 generic and 13 disease-specific questions that allow for assessment of the following:
-Performance (meant as the experiences concerning the functioning of medical practices and healthcare workers for each care aspect) -Importance (defined as the weight that patients assign to various care aspects) of 8 care dimensions: competence, autonomy, courtesy, accessibility, information, costs, continuity of care, and accommodation. The importance and performance were measured for all the items on a four-point response scale.
The combined effect of importance and performance is defined as the Quality Impact (QI). All the questionnaires with at least 7 parameters evaluated (of the 8 considered) were assessed for the total Quality Impact. The average of the scores was calculated for the scores of the parameters evaluated. A detailed list of QUOTE-IBD questions is provided in Appendix 1. The QUOTE IBD questionnaire was developed and validated by the scientific group EC-IBD (European Community -Inflammatory Bowel Disease), which represents 12 countries throughout Europe. The Italian version of the QUOTE-IBD questionnaire was used in previous studies in Italy [5] . The physicians' perspective on the QoC provided was investigated by a similar questionnaire ("Doctor's QUOTE-IBD"), which includes all the previous care dimensions of the previously developed questionnaire, excluding the dimension "accommodation" [5] . The scoring system was the same as for the patients. Physicians were included if they signed informed consent for study participation and were evaluated if they completed at least one item of the electronic case report form (e-CRF). The physician's questionnaire included questions about the type of specialisation, years of experience in the field of IBD, hours of annual refresher training, number of patients with IBD followed and weekly number of hours worked in an IBD outpatient clinic. The questionnaire was administered to physicians treating IBD patients in the IBD centres participating in the study [5] . The local ethics committees approved the present study.
Statistical analysis
For the QUOTE-IBD questionnaire, only fully completed scales were considered evaluable for the statistical analysis, i.e., no re-coding or interpolation of missing data was performed.
For every category of the QUOTE IBD, a Quality Impact (QI) score [6] was calculated based on the importance and performance scores. The Quality Impact score ranged between 0 and 10. The Quality Impact for total care was calculated as the average of the QI's from each category. In this case, patients with at least seven out of eight categories scores calculated were considered eligible for the analyses.
For every care dimension (total care, accessibility, costs, accommodation, continuity of care, courtesy, information, competence, and autonomy), a Quality Impact score equal to or greater than 9 was considered as patient satisfaction [6] . The Chi square test (or Fisher exact test or Wilcoxon test when appropriate) was performed to investigate differences in the Quality Impact scores for different subgroups: -Crohn's disease versus ulcerative colitis -patients in remission versus patients with active disease -men versus women -different age groups (≤30 years old, age between 30 and 50 years old, N50 years old). -patients in remission versus patients with active disease -different medical treatments (antiTNF and/or Immunosuppressants, steroids, no major treatment).
To assess the influence of the number of outpatient visits in the 12 months prior to baseline on the perceived QoC, univariate logistic models were developed having as outcome (Y) the score of quality of care. The likelihood of the model was calculated for quality of care ≥ 9. Significance was set as a two-tailed p-value of 0.05. As measures of disease activity, the Harvey-Bradshaw Index (HBI) [7] was used for Crohn's disease, and the Lichtiger Index was used for ulcerative colitis [8] cases. Disease remission was defined as a score less than 4 for the HBI [7] and a score less than 3 for the Lichtiger Index [8] .
We compared the patients' and physicians' perceptions of QoC.
According to the null hypothesis of being able to note relevant differences between subgroups of 0.5 points of Quality Impact, assuming alpha and beta errors of 0.05, the pre-calculated sample size was 840 patients in the two subgroups.
The statistical analyses were performed using SAS for Windows, release 9.2 (SAS Institute Inc., Cary, NC, USA). The project management, including data banking, quality control and statistical analysis, was performed by MEDIDATA (Modena, Italy).
Results
Thirty-six gastroenterology centres participated in the study from 14 Italian regions, ten university hospitals and twenty-six community hospitals. The largest numbers of patients were enrolled by centres in the northern part of Italy (64% vs. 21% in south Italy and 15% in central Italy).
Study population

Patients
One thousand and fourteen patients were enrolled. Twenty-two patients were excluded due to major protocol violations. A total of 992 patients were evaluated for the study. The majority of patients were males (55%) [53% CD, 57% UC]. Regarding the gender distribution in Italy, according to the ISTAT 2010 estimation, males account for 48% of the total Italian population [9] . The mean age of disease onset was under 40 yrs [34.3, SD 13.7], with a younger age [31.9 SD 13] (p b 0.001) in the CD group of patients. The patients mostly had a disease duration of more than 3 years (77.8%), and most of the patients were outpatients (95) with inactive disease (68%). The mean value of the Harvey Bradshaw score index for CD was 3.55 (range 0-25). The mean value of the Lichtiger score index for UC was 3.09 (range 0-19). Table 1 shows the patients' characteristics.
Medical treatment & diagnostic examinations.
Almost all the IBD patients (95%) were under medical treatment at the enrolment in the study [95.5% UC; 94% CD]. Eighty-four percent (N = 426) of UC patients were taking oral 5-ASAs (including sulfasalazine); in two-thirds of cases, ASA was used as the single treatment. Fewer CD patients were taking ASA compared with UC patients, yet more than half of CD patients were on 5-ASA (53%, p b 0.0001). Systemic corticosteroids were limited to a minority of patients (13%) with a length of treatment within three months in 75% of the population in either group of diseases (p = 0.1691). Fifty percent of patients were on immunomodulators (thiopurines and/or anti-TNFα). A significantly higher number of CD patients were on biological therapy [Infliximab/Adalimumab] (32% vs. 14% of UC patients, p b 0.0001), and most were on monotherapy (97%). Table 2 reports the individual therapies in use during the previous 12 months and at the time of enrolment. Almost all of the patients (96%) underwent blood examinations within the last 12 months, and 69% underwent diagnostic examinations (74% CD, 64% UC).
Physicians
Seventy-five physicians were enrolled; three who did not answer at least one item of the questionnaire were excluded from the evaluation. Almost all the physicians were gastroenterologists (67/72, 93%), and the majority of doctors were involved in the care of IBD patients for a long period of time (median 12 years, range 1-35) with adequate time for training and education (50 h/yr. median, range 10-300). The number of hours per week of outpatient clinic activity for IBD patients was 8.0 (median, range 1-25) with 40 consultations per month (median, range 1-180).
QUOTE IBD analysis
4.2.1. The patients.A Quality Impact score higher than 9.0, regarded as patient satisfaction, was reported for all the care sub-dimensions related to the care provided in the previous 12 months except for "Continuity of Care" (8.4 mean, SD 1.40). Within this care sub-dimension, the item associated with the lower Quality Impact score (5.41, SD 3.79) was the care guaranteed by the same physician; this item was considered important by the patients (importance score 6.36, SD 2.90) but unattended to (performance score 0.71, SD 0.45). This result was unrelated to the type of disease, either UC or CD, the disease activity and duration, previous treatments, age group, marital status or occupational condition, though there was a trend toward higher scores found in the older age class (N 50 yrs.) (p b 0.0005) mostly referring to the care sub-dimensions of "accommodation" and "courtesy". The "Continuity of Care" was perceived worse by UC patients enrolled by community hospitals (score ≥ 9: 28.4% vs 43.8%) in comparison with patients followed in University ones.
For the "importance" perspective, the patients gave a higher score to the items related to an "appropriate information about diagnostic procedures" (7.70 mean, SD 2.33) and to "the confidence in their own doctor" (8.64 SD 2.08). Lower scores were assigned to the generic items concerning the "keeping waiting more than 15 minutes" (2.20 mean, SD 2.76) and the "possibility of a specialist consultation within 2 weeks" (287 mean, SD 2.88). For the "performance" prospective, patients gave higher scores to the "quality of the information about medicines and examinations" (0.02 mean, SD 0.16) and the "confidence in their own doctor" (0.01 mean, SD 0.12). The chance to be "seen by the same doctor" received the worst score (0.71 mean, SD 0.45). There was no cross-correlation between Quality Impact scores and frequency of specialist visits (UC: OR 1.023 CI 95% 0.919-1.137; CD: OR 1.028 CI 95% 0.947-1.116) or medical treatments undertaken within the previous 12 months (Fig. 1) or disease activity measured at the basal visit (Fig. 2 ). There were no differences in terms of Quality Impact score between centres in the North or Central/South of Italy.
The physicians.
In terms of the physician's perception of the QoC, the scores of the care sub-dimensions "costs" (8.26 mean, SD 3.19) and "competence" (8.55 mean, SD 1.81) were lower than 9.0. In this framework, competence relates to the psychological approach to the patient and family. Longer experiences with IBD patients affect the perception of the QoC (Fig. 3.) The time span of 12 years of clinical activity of IBD was selected as a threshold value for the identification of physicians with high experience. The selected value corresponds to the average (median value) experience of the physicians enrolled in the study. The provision of care was perceived worse by physicians with less experience with regard to the dimensions of "competence" (8.0 mean, SD 2.08 vs. 9.01 mean, SD 1.43, p = 0.0150), "courtesy" (8.12 mean, SD 3.24 vs. 10.0 mean, SD 0.0, p = 0.0005), and "autonomy" (8.97 mean, SD 2.56 vs. 10.0 mean, SD 0.0, p =0.0170). All the physicians considered that the care dimension of "costs" could improve.
4.2.3.
Opinions of physicians and patients. Table 3 presents the care scores given by the patients and the physicians. The perceptions of IBD patients and their treating physicians differed markedly with regard to most aspects of healthcare. The patients scored the total care significantly higher than physicians did. The sub-dimensions of "competence" and "costs" were scored significantly higher by patients, and the physicians scored the subdimensions of "information" and "continuity of care" significantly higher.
Discussion
In modern healthcare, there is often a gap between the expected level of healthcare delivery and the actual healthcare provided; a consensus is emerging that poor quality in the healthcare provided to the patients contributes to adverse outcomes and increases overall costs [10, 11] . The quality of care was shown to directly influence the health-related quality of life [5] , which is an important outcome of disease cure [12] . A special focus on the measurement of quality of healthcares is typical of countries with more advanced organisational culture [13, 14] .
It should be remembered that the perception of patients about their healthcare might be independent from what might be measured by technical quality indicators [15] . The degree of patients' satisfaction with their healthcare is associated with significantly lower emergency admissions and with a better rating of their physical and mental health [10] . In IBD patients, the perception of the illness and of the healthcare seems to be similar to that reported by patients with other chronic diseases [16] .
One essential area of interest for patients and physicians is the delivery of disease-specific information because it might help patients to be better engaged with their therapeutic plans [17] and help doctors to better address requests for non-beneficial interventions [18] , maximising the cost/benefit ratio of care.
IBD-specific quality of healthcare was reviewed from the US [2] and the European [19] perspectives, although the exercise is challenging because of the differences in the patients' and healthcare providers' perspectives of the issue [20] .
The perception of the quality of healthcare might differ remarkably among different countries [16, [19] [20] [21] [22] . Therefore, it is essential that disease-specific and country-specific data are implemented because the patients' and the physicians' perspectives on QoC might be substantially affected by National Health Systems and social organisation.
The quality of care in the patients' view was analysed using different instruments [23] [24] [25] ; comparisons between studies are difficult, nonetheless it might be assumed that patients' expectations vary considerably across different countries and health systems, with major impacts on the QoC perceptions. The quality of healthcare should be measured using specific and well-validated questionnaires, such as the QUOTE-IBD questionnaire [6] or the Patient Assessment of Chronic Illness Care (PACIC) instruments [26] . These robust analytical instruments correlate closely with the perceived quality of life, and they might offer essential data for planning and implementing improvements of care delivered by given health systems [19] . For the purposes of this study, we selected the QUOTE-IBD questionnaire [5] because the ECCO acknowledged it as an essential tool in QoC research [19] .
A notable result is that in Italian IBD patients, the perception of the quality of care provided overcame the satisfaction cut-off in more than 80% of UC patients in all the care dimensions except "continuity of care" (scored satisfactory only in 33% cases) and "information" (scored satisfactory in 72% cases) dimensions. No major differences in the patientperceived QoC was noted when stratifications according to disease subtype, gender, age groups, disease activity or being managed in a low/high volume IBD centre were considered.
When these results are compared to Dutch [6] or mixedEuropean [12, 27] population results, the "continuity of care" dimension was scored over 90% in most cases, while the "information" domain was also scored lower in the original Dutch population where the QUOTE-IBD was developed [6] .
Previous data demonstrated a range of variability in the perceived quality of healthcare provided when the patients' and the physicians' perceptions were considered [5] . The results of this study are in accordance with previous data exploring the patients' and physicians' ratings of the quality of care.
When the overall "quality of care" is concerned, in the present series, the physicians rated the issue as significantly more unsatisfactory compared with the patients (p = 0.001), and the difference is likely to be substantially influenced by lower ratings given by younger (with b 12 years of practice experience) doctors (considering ratings from doctors with b 12 or ≥ 12 years of experience, respectively). Differences in the scoring between physicians and patients might be related to higher expectations of physicians regarding their potential performance; the "competence" dimension (ability to understand and manage problems) was judged as unsatisfactory by more than half of the physicians and by only 13% of patients (p b 0.0001).
Other highly significant differences (with p values b 0.001) in the perceptions between physicians and patients, with opposite directions, were observed in the "continuity of care" (satisfactory for more than 2/3 of the doctors and for only slightly more than 1/3 of the patients) and the "costs" (unsatisfactory for 1/4 doctors and only 8% of the patients) dimensions. The perception of the "information" domain was scored significantly different by the physicians (satisfaction in N 90% of the cases) and the patients (satisfaction in less than 3/4 of the cases).
An additional explanation for the observed differences between the perceptions of older and younger physicians might be explained by the fact that older physicians might rely more on their own accumulated experiences to provide adequate levels of care.
This study measured IBD-specific quality of care perceptions by patients and physicians in a large Italian cohort. The perceived quality of care was overall satisfactory for the patients and for the physicians, although conflicting perceptions were highlighted by this study. The physicians tended to underestimate their competence in the management of patients' problems and to consider problematic the cost aspects of medical management, and the patients were more critical about the continuity of care and the information provided. Substantial differences compared with other studies based on different social and health system models might be attributable to different expectations of patients and healthcare workers.
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